Automated interviews to validate distress measures in cancer survivors

自动访谈以验证癌症幸存者的痛苦措施

基本信息

  • 批准号:
    8301158
  • 负责人:
  • 金额:
    $ 18.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In addition to physical health effects, cancer survivors are known to be at increased risk for a variety of long- term psychosocial effects, most commonly depression and anxiety.3, 7-12 Young adult (YA) survivors are a particularly vulnerable group, as cancer disrupts their physical and emotional development, and they will live with late-effects for many years after treatment.12, 15-18 Studies of YA survivors show high rates of psychological distress,10, 19 as well as many barriers to receiving appropriate psychosocial care.12, 20, 21 Research to understand the etiology of these psychological late-effects and to identify and treat affected survivors has benefited from the use of self-report symptom checklists developed for psychiatric populations,12-14 but almost no research has been done to validate these measures in cancer survivors. In fact, reviews of YA survivor care consistently note that both research and patient care are hampered by a lack of patient reported outcome (PRO) measures that have been validated for this population.15, 20, 21 To address this critical need, this study investigates validity of existing measures of anxiety and depression by comparing them to a validated psychiatric assessment in a sample of 200 YA cancer survivors (age 18-40). Using the Structured Clinical Interview for DSM Disorders (SCID) 22 as a "gold standard," the validity of the Brief Symptom Inventory-18 (BSI- 18), 23 and PROMIS initiative 24, 25 anxiety and depression short forms will be assessed. Previous research supports reliability of the BSI-18 and PROMIS measures, 13, 24, and 25, 27 but no studies have validated them against a psychiatric diagnostic criterion. In addition to checklist measures, validity and utility of an innovative diagnostic interview, the Primary Care Evaluation of Mental Disorders (PRIME-MD), administered using computerized automated telephone interview (ATI) will also be investigated. Studies have validated both in-person and ATI versions of PRIME-MD in psychiatric and medical patients, 28-31 but this will be the first to study its utility in cance survivors. Analysis will focus on identifying case-rules for study measures to optimize identification of survivors with clinically significant depression and anxiety on the SCID. The study will also assess whether survivors are more comfortable disclosing sensitive information regarding sexual and suicidal symptoms using ATI compared to written forms, with the goal of determining if ATI enhances reporting of these important but often neglected symptoms. By examining the criterion validity of these measures, and identifying best methods for using them to detect survivors with clinically significant psychological symptoms, this study will greatly enhance the value of these measures and provide new approaches for research and clinical care of YA survivors. Although this research takes place in the context of YA cancer survivorship, results will be informative for developing best practices for enhancing PRO measures of psychological distress and sensitive behaviors in other populations. PUBLIC HEALTH RELEVANCE: Young adult cancer survivors experience significant disruptions in their physical and emotional development, leaving them at risk for psychological distress even many years after treatment. Research to uncover the risk factors for these psychological late-effects, and to identify and treat affected survivors has been hampered by a lack of self-report distress measures that have been validated in this population. By identifying the best methods for using self-report measures to detect young adult survivors with clinically significant psychological distress, this study makes an important contribution to research and clinical care of young adult cancer survivors.
描述(由申请人提供):除了身体健康影响外,癌症幸存者已知面临各种长期心理社会影响的风险增加,最常见的是抑郁和焦虑。3,7 -12年轻成人(YA)幸存者是一个特别脆弱的群体,因为癌症扰乱了他们的身体和情感发展,他们在治疗后的许多年里都会受到晚期影响。12,15 -18对青少年青少年幸存者的研究表明,心理困扰的发生率很高,10,19以及在接受适当的社会心理护理方面存在许多障碍。12,20,21研究了解这些心理晚期效应的病因,并识别和治疗受影响的幸存者,得益于使用为精神病学人群开发的自我报告症状检查表,但几乎没有研究在癌症幸存者中验证这些措施。事实上,对YA幸存者护理的回顾一致指出,由于缺乏对该人群进行验证的患者报告结果(PRO)措施,研究和患者护理都受到了阻碍。15,20,21为了解决这一关键需求,本研究调查了现有焦虑和抑郁测量方法的有效性

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher John Recklitis其他文献

Christopher John Recklitis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher John Recklitis', 18)}}的其他基金

STEP-YA: An Online Self-Management Intervention for Young Adult Cancer Survivors with Insomnia
STEP-YA:针对失眠的年轻成年癌症幸存者的在线自我管理干预措施
  • 批准号:
    10458886
  • 财政年份:
    2022
  • 资助金额:
    $ 18.85万
  • 项目类别:
STEP-YA: An Online Self-Management Intervention for Young Adult Cancer Survivors with Insomnia
STEP-YA:针对失眠的年轻成年癌症幸存者的在线自我管理干预措施
  • 批准号:
    10630334
  • 财政年份:
    2022
  • 资助金额:
    $ 18.85万
  • 项目类别:
Sleep Treatment Education Program-1 (STEP-1): A Randomized Trial of a Self-Management Insomnia Intervention for Cancer Survivors
睡眠治疗教育计划-1 (STEP-1):癌症幸存者自我管理失眠干预的随机试验
  • 批准号:
    10524472
  • 财政年份:
    2022
  • 资助金额:
    $ 18.85万
  • 项目类别:
Sleep Treatment Education Program-1 (STEP-1): A Randomized Trial of a Self-Management Insomnia Intervention for Cancer Survivors
睡眠治疗教育计划-1 (STEP-1):癌症幸存者自我管理失眠干预的随机试验
  • 批准号:
    10656572
  • 财政年份:
    2022
  • 资助金额:
    $ 18.85万
  • 项目类别:
CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors
CBTI-CS:一种治疗癌症幸存者失眠的新型认知行为疗法
  • 批准号:
    9190366
  • 财政年份:
    2016
  • 资助金额:
    $ 18.85万
  • 项目类别:
Automated interviews to validate distress measures in cancer survivors
自动访谈以验证癌症幸存者的痛苦措施
  • 批准号:
    8446988
  • 财政年份:
    2012
  • 资助金额:
    $ 18.85万
  • 项目类别:
Enhanced Self-Appraisal After Cancer: A Bias in Survivors' Self-Report?
癌症后自我评价增强:幸存者自我报告存在偏见?
  • 批准号:
    8038230
  • 财政年份:
    2010
  • 资助金额:
    $ 18.85万
  • 项目类别:
Enhanced Self-Appraisal After Cancer: A Bias in Survivors' Self-Report?
癌症后自我评价增强:幸存者自我报告存在偏见?
  • 批准号:
    7752638
  • 财政年份:
    2009
  • 资助金额:
    $ 18.85万
  • 项目类别:
Enhanced Self-Appraisal After Cancer: A Bias in Survivors' Self-Report?
癌症后自我评价增强:幸存者自我报告存在偏见?
  • 批准号:
    7877031
  • 财政年份:
    2009
  • 资助金额:
    $ 18.85万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.85万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了